Jae is a member of the FDA Practice Group, and focuses her practice on regulatory, transactional, and litigation matters impacting clients in the life sciences and consumer products industries.

She provides regulatory counseling and risk management advice to clients on state and federal regulatory matters to help them balance their regulatory responsibilities with their business needs. As part of her regulatory practice, Jae regularly assists clients with state and federal licensing and registration requirements, recall management, reviewing product labels and promotional materials, preparing agreements pertaining to quality and regulatory issues, and conducting regulatory due diligence on behalf of clients in corporate transactions. Jae also has extensive experience with assisting companies on navigating federal and state COVID-19 requirements, including FDA's Emergency Use Authorization process and enforcement discretion policies for personal protective equipment (such as face masks, face shields, gowns, gloves) as well as hand sanitizers and other medical products. 

Her broad regulatory practice encompasses a wide range of products, including medical devices, drugs, dietary supplements, foods and beverages, alcohol, and cosmetics. She also has experience defending large multinational companies in product liability, false advertising, and commercial litigation.

Jae serves on the Philadelphia office's Hiring Committee and Diversity & Inclusion Committee, and is a board member on the Legal Intelligencer's YL Editorial Board.